GeneMatrix Inc (109820) — Capital Reinvestment Ratio
Latest as of September 2025:
0.05x
GeneMatrix Inc (109820) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩500.19 Million) in capital expenditures (₩23.65 Million). See cash generation quality of GeneMatrix Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
₩500.19 Million
KRW
Capital Expenditures
₩23.65 Million
KRW
Data as of
Sep 2025
Most recent filing
GeneMatrix Inc Capital Reinvestment Ratio (2020–2021)
This chart tracks GeneMatrix Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for GeneMatrix Inc (2020–2021)
Year-by-year Capital Reinvestment Ratio for GeneMatrix Inc from 2020 to 2021. For live market cap and broader valuation context, see GeneMatrix Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.08x | ₩3.37 Billion | ₩258.22 Million | ▼ -5.8% |
| 2020 | 0.08x | ₩4.51 Billion | ₩366.56 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow